FRESNO, Calif., Oct. 9, 2019 /PRNewswire/ -- NEURO-PAIN MEDICAL CENTER is recruiting for a clinical research study to
Recruitment and patient care are led by Perminder Bhatia and his team until fall 2019.
What is Parkinson's disease psychosis?
Parkinson's disease is a neurodegenerative condition. This means that patients with Parkinson's disease have their brain change over time, causing problems like losing control of how their body moves. They may also experience other symptoms such as visual hallucinations (seeing things that aren't actually there), delusions (such as paranoia), or illusions (thinking something is real when it is not). These symptoms are often referred to as 'Parkinson's disease psychosis', which is common in people with Parkinson's disease.
About the SEP361-203 study
The SEP361-203 study is evaluating an investigational medication for people with Parkinson's disease that may be experiencing visual hallucinations and/or delusions. Approximately 36 people across 20 clinical research sites in the US will take part in the study. The study will evaluate how safe the investigational medication is and how well it works.
To qualify for this study, patients must be screened to determine their eligibility and agree to participate.
All study-related visits, tests, and study medication will be provided at no cost for the duration of the study. In addition, reimbursement for travel and related expenses may be provided for completed study visits.
To find out more about the SEP361-203 study, visit www.pdpclinicaltrial.com or ClinicalTrials.gov (NCT0299369).
Deciding to take part in a clinical research study is an important decision. For questions, please contact the study team using the details below.
NEURO-PAIN MEDICAL CENTER736 E BULLARD AVE, SUITE 101. FRESNO, CA 93710PH NO 559-437-9700
About NEURO-PAIN MEDICAL CENTER
NEURO-PAIN MEDICAL CENTER is a clinic in Fresno, California, that treats patients with neurological diseases and conducts clinical trials in neurological diseases.
NEURO-PAIN MEDICAL CENTER
View original content:http://www.prnewswire.com/news-releases/neuro-pain-medical-center-is-recruiting-for-clinical-study-to-evaluate-investigational-drug-for-parkinsons-300934492.html
SOURCE NEURO-PAIN MEDICAL CENTER